FISH BCL6 3q27 Gene Rearrangement Test
Comprehensive Genetic Analysis for Lymphoma Diagnosis
The FISH BCL6 3q27 Gene Rearrangement test represents a cutting-edge molecular diagnostic approach that plays a pivotal role in modern oncology practice. This specialized genetic test utilizes fluorescence in situ hybridization (FISH) technology to detect specific chromosomal abnormalities involving the BCL6 gene located at chromosome 3q27. As a critical component of comprehensive lymphoma evaluation, this test provides essential information that directly influences treatment planning and prognostic assessment.
What Does the FISH BCL6 3q27 Test Measure?
This advanced genetic test specifically targets and analyzes the BCL6 gene, which encodes a transcriptional repressor protein crucial for normal B-cell development and germinal center formation. The test detects:
- Chromosomal rearrangements involving the BCL6 gene locus at 3q27
- Translocations that disrupt normal BCL6 gene function
- Genetic abnormalities associated with specific lymphoma subtypes
- Molecular markers that influence treatment response and disease progression
Who Should Consider This Genetic Test?
This specialized diagnostic test is recommended for individuals presenting with:
- Suspected or confirmed B-cell lymphomas, particularly diffuse large B-cell lymphoma (DLBCL)
- Unexplained lymphadenopathy or enlarged lymph nodes
- Abnormal B-cell proliferation detected in previous testing
- Cases requiring precise lymphoma classification for treatment planning
- Patients with aggressive lymphoma features requiring comprehensive genetic profiling
Clinical Benefits of BCL6 Gene Rearrangement Testing
Undergoing the FISH BCL6 3q27 test provides numerous clinical advantages:
- Accurate Diagnosis: Enables precise classification of lymphoma subtypes
- Treatment Guidance: Informs targeted therapy selection based on genetic profile
- Prognostic Information: Helps predict disease behavior and treatment response
- Personalized Care: Supports development of individualized treatment strategies
- Monitoring Capability: Provides baseline genetic information for disease monitoring
Understanding Your Test Results
Your FISH BCL6 3q27 test results will be carefully interpreted by our expert genetic specialists:
- Positive Result: Indicates the presence of BCL6 gene rearrangement, which may influence lymphoma classification and treatment approach
- Negative Result: Suggests absence of detectable BCL6 rearrangements, though other genetic abnormalities may still be present
- Interpretation: Results are correlated with clinical findings and other diagnostic tests
- Clinical Correlation: Your oncologist will integrate these findings with your complete clinical picture
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $226 |
| Regular Price | $300 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Book Your Genetic Test Today
Take the next step in your diagnostic journey with confidence. Our experienced genetic counselors and oncology specialists are ready to assist you with scheduling, sample collection, and result interpretation. Contact us today to schedule your FISH BCL6 3q27 Gene Rearrangement test.
Call or WhatsApp: +1(267) 388-9828
Important Note: The FISH BCL6 3q27 test requires a physician’s prescription for diagnostic purposes. Prescription requirements may not apply to surgical cases, pregnancy-related testing, or individuals planning international travel. Our team will guide you through the necessary pre-test requirements and ensure proper sample collection from tumor tissue specimens.
